Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl compounds as IRAK inhibitors and uses thereof

Heteroaryl compounds as IRAK inhibitors and uses thereof

US Patent 9790221 · Granted Oct 17, 2017

Estimated economic value: $91,258,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Substituted pyrazoles as type II IRAK inhibitors2024
Substituted pyrazoles as type II IRAK inhibitors2024
Pyrimidinone derivatives as SHP2 antagonists2023
Pyrimidinone derivatives as SHP2 antagonists2023
Carboxamide-pyrimidine derivatives as SHP2 antagonists2023
Carboxamide-pyrimidine derivatives as SHP2 antagonists2023
Quinoline compounds as IRAK inhibitors and uses thereof2023
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Pyrazole compounds as modulators of FSHR and uses thereof2022
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021